Can Trevi Therapeutics Address The Big Unmet Need In Chronic Cough?

AI Briefing

• – Trevi Therapeutics Inc. starts pivotal trial for IPF-related chronic cough this quarter.
• – Positive data from chronic cough programs drives momentum for the company.
• – Trevi Therapeutics seeks to address the unmet need in treating chronic cough.